Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Cholecystokinin release pathway" refers to a signaling pathway—an organized sequence of molecular events regulating the release of the peptide hormone cholecystokinin (CCK)—rather than to a specific molecule, protein, or canonical therapeutic target such as a receptor, enzyme, or transporter. The pathway involves the sensing of dietary fats and amino acids by enteroendocrine I cells in the small intestine, leading to CCK secretion, which then acts through G protein-coupled receptors (CCK1/CCK2) to regulate digestive processes[1][2][3][5][6][7]. As such, it is not considered a therapeutic "target" in the usual molecular sense, and the entry is too broad to map directly to the structure requested.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cholecystokinin release pathway.